Home parenteral nutrition for advanced cancer patients: Contributes to survival?
Autor: | Joelle Attal-Singer, Miriam Theilla, Ilia Kagan, J Cohen, Pierre Singer, Shaul Lev |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Palliative care Endocrinology Diabetes and Metabolism Population Kaplan-Meier Estimate Severity of Illness Index Enteral administration Hospitalization rate 03 medical and health sciences 0302 clinical medicine Neoplasms Internal medicine medicine Humans Intensive care medicine education Aged Aged 80 and over education.field_of_study 030109 nutrition & dietetics Nutrition and Dietetics business.industry Patient Selection Malnutrition Palliative Care Middle Aged medicine.disease Advanced cancer Palliative Therapy Parenteral nutrition 030220 oncology & carcinogenesis Female Parenteral Nutrition Home business Intestinal Obstruction |
Zdroj: | Nutrition. 54:197-200 |
ISSN: | 0899-9007 |
DOI: | 10.1016/j.nut.2017.03.005 |
Popis: | Objectives Patients with advanced cancer often suffer from severe malnutrition and gastrointestinal obstruction. This population could benefit from home parenteral nutrition (HPN). The aim of this study was to observe the outcome of patients with advanced cancer patients who were eligible for HPN. Methods All patients in the nutrition clinic who received HPN over the past 7 y were included in the present study. We compared patients with advanced cancer with the noncancer population in terms of hospitalization rate and mortality. Results Of 221 advanced cancer patients, 153 who had no oral/enteral intake and who received HPN survived. Of these, 35% survived for 6 mo, 27% for 1 y, 18.9% survived 2 y, and 3.9% survived for the 7 y of the follow-up. Hospitalization rate was not significantly different from the noncancer population. Conclusion These results show that HPN is a relevant palliative therapy for patients with advanced cancer patients without oral or enteral feeding access. |
Databáze: | OpenAIRE |
Externí odkaz: |